Statistics

Total Visits

Views
Cabazitaxel in patients with advanced CRPC after Docetaxel-Failure. Results of expanded Program access(EAP) in Spain: Safety and efficacy.48

Select a period of time:

Number of views in the range

Views
Cabazitaxel in patients with advanced CRPC after Docetaxel-Failure. Results of expanded Program access(EAP) in Spain: Safety and efficacy.23

Views

Views
May 20251
June 20250
July 202515
August 20250
September 20250
October 20251
November 20256
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil14
United States2
United Kingdom2
Austria1
Germany1
Hong Kong1
Morocco1
Senegal1
 

Top cities views

Views
São Paulo2
Ashton-under-Lyne1
Barbacena1
Belo Horizonte1
Dakar1
Frankfurt am Main1
Gracilândia1
Hong Kong1
Iporá1
Itabira1